Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald F Smee

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|August 1, 2009
Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cellsDonald F Smee, Brett L Hurst, Hiroyuki Egawa, et al.
The Journal of Infectious Diseases|August 21, 2004
Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised miceDonald F Smee, Kevin W Bailey, Min-Hui Wong, et al.
Antiviral Research|October 3, 2013
Favipiravir (T-705), a novel viral RNA polymerase inhibitorYousuke Furuta, Brian B Gowen, Kazumi Takahashi, et al.
Antiviral Research|May 20, 2014
The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infectionJustin G Julander, Kyle Kesler, Arnaud J Van Wettere, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2009
Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Research|April 12, 2016
Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compoundsDonald F Smee, W Joseph Evans, K C Nicolaou, et al.
Antiviral Chemistry & Chemotherapy|November 13, 2004
Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidineDonald F Smee, Miles K Wandersee, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|December 21, 2006
Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivativesPeriyasamy Selvam, Narayanan Murugesh, Markandavel Chandramohan, et al.
Antiviral Research|January 15, 2017
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A virusesYanmei Hu, Rami Musharrafieh, Chunlong Ma, et al.
Virology|November 4, 2018
Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in miceBrett L Hurst, W Joseph Evans, Donald F Smee, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|August 1, 2009
Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cellsDonald F Smee, Brett L Hurst, Hiroyuki Egawa, et al.
The Journal of Infectious Diseases|August 21, 2004
Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised miceDonald F Smee, Kevin W Bailey, Min-Hui Wong, et al.
Antiviral Research|October 3, 2013
Favipiravir (T-705), a novel viral RNA polymerase inhibitorYousuke Furuta, Brian B Gowen, Kazumi Takahashi, et al.
Antiviral Research|May 20, 2014
The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infectionJustin G Julander, Kyle Kesler, Arnaud J Van Wettere, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2009
Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Research|April 12, 2016
Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compoundsDonald F Smee, W Joseph Evans, K C Nicolaou, et al.
Antiviral Chemistry & Chemotherapy|November 13, 2004
Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidineDonald F Smee, Miles K Wandersee, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|December 21, 2006
Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivativesPeriyasamy Selvam, Narayanan Murugesh, Markandavel Chandramohan, et al.
Antiviral Research|January 15, 2017
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A virusesYanmei Hu, Rami Musharrafieh, Chunlong Ma, et al.
Virology|November 4, 2018
Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in miceBrett L Hurst, W Joseph Evans, Donald F Smee, et al.
Pageof 13